Patent US5262423A successfully refreshed from Google Patents.
US5262423A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Rapamycin arylcarbonyl and alkoxycarbonyl carbamates as immunosuppressive and antifungal agents
Assignee: Wyeth LLC
•
Filing: 1992-10-29
•
Granted: 1993-11-16
•
Expires: 2012-10-29
Abstract
Abstract N-arylcarbonyl and N-alkylcarbonyl carbamates of rapamycin of the formula shown below wherein ##STR1## R 1 and R 2 are both ##STR2## and where A is lower alkoxy or aryl or heteroaryl, R 3 is H or methyl and R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl or C 2 -C 6 alkynyl possess immunosuppressive and/or antifungal and/or antitumor and/or antiinflammatory activity in vitro and/or inhibit thymocyte proliferation in vivo. These compounds are thus expected to be useful in the treatment of transplantation rejection, autoimmune diseases, fungal infections, cancer, and diseases of inflammation.
Inventors
- 👤 Wenling Kao
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-08 05:40
CPC Classifications
C; C07; C07D; C07D498/00; C07D498/12; C07D498/18; A; A61; A61P; A61P29/00; A61P31/00; A61P31/10; A61P37/00; A61P37/02; A61P37/06
Claims Analysis
Total Claims: 12
Claim 1
Independent Claim
150 words
A compound according to the formula: ##STR12## wherein R 1 is ##STR13## and R 2 is H or ##STR14## R 1 and R 2 are both ##STR15## R 3 is H or methyl, A is --OR 4 where R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl optionally substituted fluorine, chlorine, bromine, iodine, methoxy or ethoxy; arylalkyl or 7 to 12 atoms, aryl selected from phenyl or phenyl substituted by one or two groups selected from fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, cyano; naphthalenyl, naphthalenyl substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, fluorine, chlorine, bromine or iodine; heteroaryl selected from pyridinyl, pyrimidinyl, pyrazinyl, indolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzopyranyl, benzo[b]thiophenyl, benzimidazolyl, benzthiazolyl; cycloalkyl selected from cyclopentyl, cyclohexyl, adamantyl; or quinuclidinyl, or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim
150 words
A compound according to the formula: ##STR12## wherein R 1 is ##STR13## and R 2 is H or ##STR14## R 1 and R 2 are both ##STR15## R 3 is H or methyl, A is --OR 4 where R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl optionally substituted fluorine, chlorine, bromine, iodine, methoxy or ethoxy; arylalkyl or 7 to 12 atoms, aryl selected from phenyl or phenyl substituted by one or two groups selected from fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, cyano; naphthalenyl, naphthalenyl substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, fluorine, chlorine, bromine or iodine; heteroaryl selected from pyridinyl, pyrimidinyl, pyrazinyl, indolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzopyranyl, benzo[b]thiophenyl, benzimidazolyl, benzthiazolyl; cycloalkyl selected from cyclopentyl, cyclohexyl, adamantyl; or quinuclidinyl, or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim
12 words
A compound according to claim 1 wherein A is phenyl or methoxy.
Claim 4
Dependent Claim
13 words
A compound according to claim 1 which is rapamycin 42-ester with benzoylcarbamic acid.
Claim 5
Dependent Claim
16 words
A compound according to claim 1 which is rapamycin 31-ester with N,N-dimethylglycine, 42-ester with benzoylcarbamic acid.
Claim 6
Dependent Claim
12 words
A compound according to claim 1 which is rapamycin-31,42-diester with benzoylcarbamic acid.
Claim 7
Dependent Claim
13 words
A compound according to claim 1 which is rapamycin 42-ester with N-methoxycarbonylcarbamic acid.
Claim 8
Independent Claim
173 words
A method of treating transplantation rejection, host vs. graft disease, and diseases of inflammation in a mammal by administering thereto an effective amount of a compound having the formula: ##STR16## wherein R 1 is ##STR17## and R 2 is H or ##STR18## R 1 and R 2 are both ##STR19## R 3 is H or methyl, A is --OR 4 where R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl optionally substituted fluorine, chlorine, bromine, iodine, methoxy or ethoxy; arylalkyl of 7 to 12 atoms, aryl selected from phenyl or phenyl substituted by one or two groups selected from fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, cyano; naphthalenyl, naphthalenyl substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, fluorine, chlorine, bromine or iodine; heteroaryl selected from pyridinyl, pyrimidinyl, pyrazinyl, indolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzopyranyl, benzothiophenyl, benzimidazolyl, benzthiazolyl; cycloalkyl selected from cyclopentyl, cyclohexyl, adamantyl; or quinuclidinyl, or a pharmaceutically acceptable salt thereof.
Claim 9
Independent Claim
173 words
A method of treating transplantation rejection, host vs. graft disease, and diseases of inflammation in a mammal by administering thereto an effective amount of a compound having the formula: ##STR16## wherein R 1 is ##STR17## and R 2 is H or ##STR18## R 1 and R 2 are both ##STR19## R 3 is H or methyl, A is --OR 4 where R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl optionally substituted fluorine, chlorine, bromine, iodine, methoxy or ethoxy; arylalkyl of 7 to 12 atoms, aryl selected from phenyl or phenyl substituted by one or two groups selected from fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, cyano; naphthalenyl, naphthalenyl substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, fluorine, chlorine, bromine or iodine; heteroaryl selected from pyridinyl, pyrimidinyl, pyrazinyl, indolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzopyranyl, benzothiophenyl, benzimidazolyl, benzthiazolyl; cycloalkyl selected from cyclopentyl, cyclohexyl, adamantyl; or quinuclidinyl, or a pharmaceutically acceptable salt thereof.
Claim 10
Dependent Claim
14 words
A method of treatment according to claim 7 wherein A is phenyl or methoxy.
Claim 11
Dependent Claim
161 words
A pharmaceutical composition comprising a pharmaceutical carrier and an effective amount of a compound of the formula: ##STR20## wherein R 1 is ##STR21## and R 2 is H or ##STR22## R 1 and R 2 are both ##STR23## R 3 is H or methyl, A is --OR 4 where R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl optionally substituted fluorine, chlorine, bromine, iodine, methoxy or ethoxy; arylalkyl of 7 to 12 atoms, aryl selected from phenyl or phenyl substituted by one or two groups selected from fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, cyano; naphthalenyl, naphthalenyl substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, fluorine, chlorine, bromine or iodine; heteroaryl selected from pyridinyl, pyrimidinyl, pyrazinyl, indolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzopyranyl, benzothiophenyl, benzimidazolyl, benzthiazolyl; cycloalkyl selected from cyclopentyl, cyclohexyl, adamantyl; or quinuclidinyl, or a pharmaceutically acceptable salt thereof.
Claim 12
Dependent Claim
161 words
A pharmaceutical composition comprising a pharmaceutical carrier and an effective amount of a compound of the formula: ##STR20## wherein R 1 is ##STR21## and R 2 is H or ##STR22## R 1 and R 2 are both ##STR23## R 3 is H or methyl, A is --OR 4 where R 4 is C 1 -C 6 alkyl, C 2 -C 6 alkenyl, or C 2 -C 6 alkynyl optionally substituted fluorine, chlorine, bromine, iodine, methoxy or ethoxy; arylalkyl of 7 to 12 atoms, aryl selected from phenyl or phenyl substituted by one or two groups selected from fluorine, chlorine, bromine, iodine, nitro, trifluoromethyl, C 1 -C 6 alkyl, C 1 -C 6 alkoxy, cyano; naphthalenyl, naphthalenyl substituted by C 1 -C 6 alkyl, C 1 -C 6 alkoxy, fluorine, chlorine, bromine or iodine; heteroaryl selected from pyridinyl, pyrimidinyl, pyrazinyl, indolyl, quinolinyl, isoquinolinyl, benzofuranyl, benzopyranyl, benzothiophenyl, benzimidazolyl, benzthiazolyl; cycloalkyl selected from cyclopentyl, cyclohexyl, adamantyl; or quinuclidinyl, or a pharmaceutically acceptable salt thereof.
References Cited (Backward Citations)
US3929992A
Cited
US3993749A
Cited
US4885171A
Cited
US4316885A
Cited
US4401653A
Cited
US4650803A
Cited
US5100899A
Cited
WO1991013899A1
Cited
US5080899A
Cited
US5078999A
Cited
US5118678A
Cited
US5091389A
Cited
US5118677A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1996-11-15 | 1997-05-17 | 1997-11-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2000-11-15 | 2001-05-17 | 2001-11-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2004-11-15 | 2005-05-17 | 2005-11-16 | $7700.00 | Window Closed / Lapsed |